Category: Baxter International
Baxter's 3rd-quarter profits beat expectations, driven by its medical product business, but shares slide on a lowered earnings forecast.
(Reuters) - Medical device and drug maker Baxter (NYSE:BAX) reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.
Baxter International confirmed Cambridge, Mass., as the new R&D hub for Baxalta, the planned spinout of its biopharmaceuticals business.
Baxter's has 'high' hopes for its coming Baxalta spinout, which will get a full visual work-up before the company goes live mid-2015.
Baxter (NYSE:BAX) crept a little closer to spinning out its biopharmaceuticals division into an independent entity by giving the company a name: Baxalta.
Here's a look at some of the top Wall Street stories for medical device companies this week: Renal denervation isn't dead, despite Medtronic trial's failure; Baxter says HQ will stay in Illinois, stays coy on Boston plans; Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity
, Apax Partners
, Baxter International
, Boston Scientific
, Centaur Guernsey
, Kinetic Concepts Inc.
, Kona Medical
, LifeCell Corp.
, ReCor Medical
, St. Jude Medical
, Systagenix Wound Management Inc.
Baxter International says it will keep its headquarters in Illinois, despite recent reports of a possible move to Boston, but stays coy on its actual plans in The Hub.
The Boston Business Journal reports that Baxter International is moving its corporate headquarters from Deerfield, Ill. to Cambridge, Mass.
MASSDEVICE ON CALL — Healthcare industry giant Baxter (NYSE:BAX) is moving its corporate headquarters to Massachusetts in a sneaky plot dubbed "Project Tiger" by Bay State economic and business officials, according to a Boston Business Journal report.
Baxter will more than double its Opelika, Ala., workforce after putting $300 million into expanding its dialyzer manufacturing facility.
Medtech titan Baxter (NYSE:BAX) is looking to hire 200 new workers to man its growing facility in Alabama as global demand grows for hemodialysis devices.